Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed director
Quarterly results
Director departure
|
|
ACHILLION PHARMACEUTICALS INC (ACHN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/17/2020 |
SC 13G/A
| ARP AMERICAS LLC reports a 5.1% stake in Achillion Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 0% stake in Achillion Pharmaceuticals, Inc. |
| 02/11/2019 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.2% stake in Achillion Pharmaceuticals Inc |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC reports a 0.4% stake in ACHILLION PHARMACEUTICALS, INC. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 3.6% stake in Achillion Pharmaceuticals, Inc. |
| 02/08/2018 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.8% stake in Achillion Pharmaceuticals Inc |
| 01/29/2018 |
SC 13G/A
| BlackRock Inc. reports a 8.4% stake in ACHILLION PHARMACEUTICALS INC |
| 11/22/2017 |
SC 13G/A
| JOHNSON & JOHNSON reports a 0% stake in Achillion Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| ACHILLION PHARMACEUTICALS INC reports a 0% stake in ACHILLION PHARMACEUTICALS, INC. |
| 02/14/2017 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/08/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/26/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/25/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/19/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 11/10/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/16/2016 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 7.7% stake in ACHILLION PHARMACEUTICALS, INC. |
| 02/12/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 08/12/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2012 |
SC 13G/A
| ACHILLION PHARMACEUTICALS INC reports a 2.7% stake in Achillion Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G/A
| ACHILLION PHARMACEUTICALS INC reports a 4.1% stake in Achillion Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G/A
| ACHILLION PHARMACEUTICALS INC reports a 15% stake in ACHILLION PHARMACEUTICALS INC |
| 02/13/2012 |
SC 13G/A
| ACHILLION PHARMACEUTICALS INC reports a 7.5% stake in Achillion Pharmaceuticals, Inc. |
| 02/11/2011 |
SC 13G/A
| INVESTOR AB reports a 3.4% stake in ACHILLION PHARMACEUTICALS, INC. |
|
|
|